Cadre Holdings, Inc.
NYSE:CDREAerospace & Defense
-$0.26 today
- Market cap
- $1.37B
- Beta
- 1.31
- P/E (TTM)
- 32.2
- EPS (TTM)
- $0.87
- Dividend yield
- 1.40%
Volume 0.47M
Average 0.41M
CDRE Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Cadre Holdings, Inc.NYSE: CDRE
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 1.9% of revenue in FY2025, up 1.9 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 11.4M USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.4M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CDRE compares with its peers on the latest reported figures
- CDRE's LTM Mar 2026 research & development of $0 is the 6th highest of the 10 companies compared; the peer median is $11M.
- Research & development amounts to 0.0% of revenue for CDRE, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $42.86M | +30.5% | — | 4.3% | |
| LTM Mar 2026 | $34.67M | -8.3% | -7.8% | 9.3% | |
| LTM Mar 2026 | $16.22M | — | — | 9.7% | |
| LTM Jun 2026 | $14.09M | -44.6% | -29.5% | 0.8% | |
| LTM Jun 2026 | $11M | — | — | 0.5% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding CDRE) | $11M | -26.5% | -18.7% | 0.5% | |
Competitors are the stored peer set for CDRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 427.29M | 457.84M | 482.53M | 567.56M | 610.31M |
| Cost of Revenue | 256.6M | 282.16M | 281.81M | 334.08M | 358.59M |
| Gross Profit | 170.69M | 175.68M | 200.73M | 233.48M | 251.72M |
| Gross Margin | 39.9% | 38.4% | 41.6% | 41.1% | 41.2% |
| Research & Development | 0 | 0 | 0 | 0 | 11.4M |
| Selling, General & Admin | 114.96M | 153.13M | 140.52M | 158.32M | 165.28M |
| Operating Expenses | 118.97M | 158.96M | 144.21M | 166.72M | 176.68M |
| Depreciation & Amortization | 13.72M | 15.65M | 15.74M | 16.42M | 18.95M |
| EBITDA | 49.34M | 31.23M | 73.19M | 78.46M | 93.11M |
| EBITDA Margin | 11.5% | 6.8% | 15.2% | 13.8% | 15.3% |
| Operating Income | 51.72M | 16.72M | 56.52M | 66.76M | 75.05M |
| Operating Margin | 12.1% | 3.7% | 11.7% | 11.8% | 12.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 16.43M | 6.21M | 4.53M | 7.82M | 11.83M |
| Other Income / Expenses | (32.53M) | (7.34M) | (3.6M) | (12.54M) | (12.72M) |
| Income Before Tax | 19.19M | 9.37M | 52.92M | 54.22M | 62.33M |
| Pre-Tax Margin | 4.5% | 2.0% | 11.0% | 9.6% | 10.2% |
| Income Tax Expense | 6.53M | 3.55M | 14.28M | 18.09M | 18.19M |
| Net Income | 12.66M | 5.82M | 38.64M | 36.13M | 44.14M |
| Net Margin | 3.0% | 1.3% | 8.0% | 6.4% | 7.2% |
| EPS (Basic) | 0.44 | 0.16 | 1.03 | 0.90 | 1.08 |
| EPS (Diluted) | 0.44 | 0.16 | 1.02 | 0.90 | 1.02 |
| Weighted Avg Shares | 28.6M | 36.11M | 37.53M | 39.95M | 40.87M |
| Weighted Avg Shares (Diluted) | 28.6M | 36.12M | 37.92M | 40.33M | 43.43M |
Cadre Holdings, Inc.
NYSE:CDRE
Intrinsic Alpha fair value
Locked
Current Price
$31.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.